Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Declaration of Final Dividend for the financial year ended March 31, 2026, is attached
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Agarwal's Eye Hospital reported FY26 revenue of Rs 470.87 crore, up 18.6% from Rs 397.15 crore in FY25, approaching but not reaching 20% revenue growth. Net profit after tax grew 28.3% to Rs 70.10 crore from Rs 54.65 crore, exceeding the 25% PAT growth signal threshold. EBITDA margin expanded slightly to 32% from 31%. The Board recommended a final dividend of Rs 4 per share (40%), which combined with the Rs 3 interim dividend already paid totals Rs 7 per share (70%) for FY26. The auditor issued an unmodified opinion confirming clean financials. The company also completed a Rs 70 crore preferential share issue to its holding company and has a pending amalgamation scheme with Dr Agarwal's Health Care Limited.
Strong profitability growth with 28% PAT increase and clean audit opinion are positive signals. The total 70% dividend payout demonstrates shareholder-friendly policy. Revenue growth of 18.6% shows solid expansion though slightly below 20% threshold.